Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,867 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04009941 | Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer | completed | Phase 4 | 104 | Peking UniversityOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| NCT03397914 | Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections | completed | Phase 4 | 70 | National Cancer Institute, EgyptOTHER | 1 | Sep 16, 2020 | clinicaltrials |
| NCT02502864 | Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide | completed | Phase 4 | 9 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 11, 2020 | clinicaltrials |
| NCT02287675 | Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer(Lymphoseek) | completed | Phase 4 | 40 | Kettering Health NetworkOTHER | 1 | Jul 28, 2020 | clinicaltrials |
| NCT04434404 | Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy | completed | Phase 4 | 83 | Horus UniversityOTHER | 1 | Jun 16, 2020 | clinicaltrials |
| NCT02816112 | Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia(REaCT-TC2) | completed | Phase 4 | 458 | Ottawa Hospital Research InstituteOTHER | 1 | May 27, 2020 | clinicaltrials |
| NCT02627560 | The Effect of Topical Tranexamic Acid on Bleeding and Seroma Formation in After Undergoing Mastectomy | completed | Phase 4 | 202 | St. Olavs HospitalOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT02005770 | Anesthesia and Circulating Tumor Cells in Breast Cancer | completed | Phase 4 | 221 | University of ZurichOTHER | 1 | Apr 14, 2020 | clinicaltrials |
| NCT04218149 | Serratus Plane Block vs Erector Spinae Plane Block on Postoperative Analgesia in Patients Undergoing Unilateral Breast Surgery | completed | Phase 4 | 70 | Sisli Hamidiye Etfal Training and Research HospitalOTHER | 1 | Jan 31, 2020 | clinicaltrials |
| NCT03348696 | Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for TAPS in Breast Cancer Patients(REaCT-TAPS) | completed | Phase 4 | 124 | Ottawa Hospital Research InstituteOTHER | 1 | Jan 9, 2020 | clinicaltrials |
| NCT03305757 | Seroma Reduction After Mastectomy(SAM) | completed | Phase 4 | 339 | Zuyderland Medisch CentrumOTHER | 1 | Dec 3, 2019 | clinicaltrials |
| NCT03125941 | High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Mastectomy(DEX-MAS) | completed | Phase 4 | 130 | Rigshospitalet, DenmarkOTHER | 1 | Dec 2, 2019 | clinicaltrials |
| NCT03583944 | A Study to Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer | completed | Phase 4 | 200 | Eisai Inc.INDUSTRY | 1 | Nov 27, 2019 | clinicaltrials |
| NCT02445586 | Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer | completed | Phase 4 | 52 | Hoffmann-La RocheINDUSTRY | 1 | Oct 29, 2019 | clinicaltrials |
| NCT02344940 | Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer(TTOS) | completed | Phase 4 | 104 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Sep 24, 2019 | clinicaltrials |
| NCT02816164 | A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia(REaCT-G2) | completed | Phase 4 | 324 | Ottawa Hospital Research InstituteOTHER | 1 | Sep 6, 2019 | clinicaltrials |
| NCT00756717 | Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer(MK-0752) | completed | Phase 4 | 22 | Loyola UniversityOTHER | 1 | Sep 4, 2019 | clinicaltrials |
| NCT03799757 | Using Bupivacaine Locally in the Mastectomy Drains to Control Postoperative Pain | completed | Phase 4 | 168 | Alexandria UniversityOTHER | 1 | Jan 10, 2019 | clinicaltrials |
| NCT01948960 | Influence of Exceptional Patient Characteristics on Everolimus Exposure(INPRES) | completed | Phase 4 | 56 | Radboud University Medical CenterOTHER | 1 | Dec 7, 2018 | clinicaltrials |
| NCT00812864 | Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥ 75 Years)(capagec) | completed | Phase 4 | 20 | University Hospital, LimogesOTHER | 1 | Aug 28, 2018 | clinicaltrials |
| NCT01537029 | Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide | completed | Phase 4 | 15 | Texas Tech University Health Sciences CenterOTHER | 1 | Aug 22, 2018 | clinicaltrials |
| NCT00772824 | Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients | completed | Phase 4 | 23 | Banaras Hindu UniversityOTHER | 1 | Jul 17, 2018 | clinicaltrials |
| NCT03586154 | Combined Intra-articular Shoulder Injection and Stellate Ganglion Block in Chronic Post-mastectomy Shoulder Pain | completed | Phase 4 | 70 | Mansoura UniversityOTHER | 1 | Jul 16, 2018 | clinicaltrials |
| NCT01501487 | MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I(MINT) | completed | Phase 4 | 226 | AgendiaINDUSTRY | 1 | Jun 28, 2018 | clinicaltrials |
| NCT01094184 | A Study of Bevacizumab With Taxane Therapy in Participants With Triple Negative Breast Cancer(BATMAN) | completed | Phase 4 | 49 | Hoffmann-La RocheINDUSTRY | 1 | Mar 22, 2018 | clinicaltrials |
| NCT03384511 | The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. | completed | Phase 4 | 38 | Shandong Cancer Hospital and InstituteOTHER | 1 | Feb 20, 2018 | clinicaltrials |
| NCT00882089 | Use of the Contura™ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients | completed | Phase 4 | 13 | Cancer Center of IrvineOTHER | 1 | Jan 25, 2018 | clinicaltrials |
| NCT00882596 | Use of the Contura™ Catheter to Deliver Accelerated Partial Breast Irradiation to "Low-risk" Breast Cancer Patients | completed | Phase 4 | 30 | Cancer Center of IrvineOTHER | 1 | Jan 25, 2018 | clinicaltrials |
| NCT02173262 | REaCT Integrated Consent Model to Compare Two Standard of Care Regimens(OTT14-03) | completed | Phase 4 | 142 | Ottawa Hospital Research InstituteOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT00485953 | Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy(REBBeCA II) | completed | Phase 4 | 109 | Susan L. GreenspanOTHER | 1 | Oct 13, 2017 | clinicaltrials |
| NCT01766102 | Intra-operative Digital vs. Standard Mammography | completed | Phase 4 | 72 | Massachusetts General HospitalOTHER | 1 | Aug 24, 2017 | clinicaltrials |
| NCT01907880 | The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer(ER11-03) | completed | Phase 4 | 74 | Ottawa Hospital Research InstituteOTHER | 1 | Jul 7, 2017 | clinicaltrials |
| NCT00872859 | The BREASTrial:Breast Reconstruction Evaluation Using Acellular Dermal Matrix as a Sling Trial | completed | Phase 4 | 128 | University of UtahOTHER | 1 | May 18, 2017 | clinicaltrials |
| NCT01781299 | Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU | completed | Phase 4 | 9 | University of PittsburghOTHER | 1 | May 12, 2017 | clinicaltrials |
| NCT00176046 | Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study | completed | Phase 4 | 114 | Heidelberg UniversityOTHER | 1 | May 8, 2017 | clinicaltrials |
| NCT00092183 | An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071) | completed | Phase 4 | 866 | Merck Sharp & Dohme LLCINDUSTRY | 0 | May 5, 2017 | clinicaltrials |
| NCT00237133 | Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women(PREDICT) | completed | Phase 4 | 112 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 24, 2017 | clinicaltrials |
| NCT00334139 | Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer | completed | Phase 4 | 411 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00372476 | Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer(INV181) | completed | Phase 4 | 33 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 7, 2017 | clinicaltrials |
| NCT01301729 | A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment | completed | Phase 4 | 32 | Hoffmann-La RocheINDUSTRY | 1 | Dec 29, 2016 | clinicaltrials |
| NCT01961544 | Eribulin Mesylate Phase IV Clinical Trial in Korean Patients With Metastatic or Locally Advanced Breast Cancer(ESKIMO) | completed | Phase 4 | 101 | Eisai Korea Inc.INDUSTRY | 1 | Oct 7, 2016 | clinicaltrials |
| NCT02805153 | PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy | completed | Phase 4 | 215 | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.INDUSTRY | 0 | Jun 20, 2016 | clinicaltrials |
| NCT02805205 | PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia | completed | Phase 4 | 484 | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.INDUSTRY | 0 | Jun 20, 2016 | clinicaltrials |
| NCT00613275 | Patient Navigation in the Safety Net:CONNECTeDD | completed | Phase 4 | 4,038 | Boston Medical CenterOTHER | 1 | Jun 15, 2016 | clinicaltrials |
| NCT00742222 | Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer(EXIBT) | completed | Phase 4 | 63 | Xoft, Inc.INDUSTRY | 1 | May 17, 2016 | clinicaltrials |
| NCT01561287 | A Comparison of Dermal Autograft to AlloDerm in Breast Reconstruction | completed | Phase 4 | 48 | University of KentuckyOTHER | 1 | May 11, 2016 | clinicaltrials |
| NCT01231204 | Prevention of Post-Mastectomy Breast Pain Using Ambulatory Continuous Paravertebral Blocks | completed | Phase 4 | 60 | University of California, San DiegoOTHER | 1 | Apr 11, 2016 | clinicaltrials |
| NCT02562170 | Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study | completed | Phase 4 | 50 | Medical University of ViennaOTHER | 1 | Sep 29, 2015 | clinicaltrials |
| NCT01199432 | Comparative Efficiency of Three Regimen, CEFci, CEF and EC as Neoadjuvant Chemotherapy for Primary Breast Cancer | completed | Phase 4 | 501 | Tao OUYANGOTHER | 1 | Jun 10, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Oct 28, 2020source: clinicaltrials